Strata Skin Sciences Company Profile (NASDAQ:SSKN)

About Strata Skin Sciences (NASDAQ:SSKN)

Strata Skin Sciences logoSTRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SSKN
  • CUSIP: N/A
  • Web: www.melasciences.com
Capitalization:
  • Market Cap: $5.76 million
  • Outstanding Shares: 2,181,000
Average Prices:
  • 50 Day Moving Avg: $2.62
  • 200 Day Moving Avg: $1.07
  • 52 Week Range: $2.14 - $5.40
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.60
  • P/E Growth: -0.04
Sales & Book Value:
  • Annual Revenue: $31.76 million
  • Price / Sales: 0.18
  • Book Value: $6.79 per share
  • Price / Book: 0.39
Profitability:
  • EBIDTA: $2.77 million
  • Net Margins: -9.33%
  • Return on Equity: -29.02%
  • Return on Assets: -10.01%
Debt:
  • Debt-to-Equity Ratio: 1.38%
  • Current Ratio: 2.03%
  • Quick Ratio: 1.33%
Misc:
  • Average Volume: 124,948 shs.
  • Beta: 1.02
  • Short Ratio: 4.74
 

Frequently Asked Questions for Strata Skin Sciences (NASDAQ:SSKN)

What is Strata Skin Sciences' stock symbol?

Strata Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

When did Strata Skin Sciences' stock split? How did Strata Skin Sciences' stock split work?

Shares of Strata Skin Sciences reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of Strata Skin Sciences stock prior to the reverse split would have 10 shares after the split.

How were Strata Skin Sciences' earnings last quarter?

Strata Skin Sciences, Inc. (NASDAQ:SSKN) issued its quarterly earnings data on Thursday, May, 12th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.08. The firm earned $7.62 million during the quarter, compared to the consensus estimate of $9.15 million. Strata Skin Sciences had a negative return on equity of 29.02% and a negative net margin of 9.33%. View Strata Skin Sciences' Earnings History.

Where is Strata Skin Sciences' stock going? Where will Strata Skin Sciences' stock price be in 2017?

1 brokers have issued 12-month price objectives for Strata Skin Sciences' stock. Their predictions range from $12.00 to $12.00. On average, they anticipate Strata Skin Sciences' share price to reach $12.00 in the next year. View Analyst Ratings for Strata Skin Sciences.

Are investors shorting Strata Skin Sciences?

Strata Skin Sciences saw a drop in short interest in the month of April. As of April 28th, there was short interest totalling 54,269 shares, a drop of 6.3% from the April 13th total of 57,937 shares. Based on an average trading volume of 265,454 shares, the short-interest ratio is currently 0.2 days.

Who are some of Strata Skin Sciences' key competitors?

Who owns Strata Skin Sciences stock?

Strata Skin Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Broadfin Capital LLC (44.08%) and Sabby Management LLC (32.46%). Company insiders that own Strata Skin Sciences stock include Frank J Mccaney and Healthcare Master Fun Broadfin. View Institutional Ownership Trends for Strata Skin Sciences.

Who sold Strata Skin Sciences stock? Who is selling Strata Skin Sciences stock?

Strata Skin Sciences' stock was sold by a variety of institutional investors in the last quarter, including Sabby Management LLC. View Insider Buying and Selling for Strata Skin Sciences.

How do I buy Strata Skin Sciences stock?

Shares of Strata Skin Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Strata Skin Sciences stock cost?

One share of Strata Skin Sciences stock can currently be purchased for approximately $2.64.

Analyst Ratings

Consensus Ratings for Strata Skin Sciences (NASDAQ:SSKN) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (354.55% upside)

Analysts' Ratings History for Strata Skin Sciences (NASDAQ:SSKN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/16/2017Rodman & RenshawBoost Price TargetBuy -> Buy$1.50 -> $12.00HighView Rating Details
8/24/2015HC WainwrightBoost Price TargetBuy$4.50 -> $5.00N/AView Rating Details
(Data available from 5/23/2015 forward)

Earnings

Earnings History for Strata Skin Sciences (NASDAQ:SSKN)
Earnings by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
Earnings History by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/12/2016Q1($0.18)($0.26)$9.15 million$7.62 millionViewListenView Earnings Details
3/10/2016Q4($0.22)($0.06)$8.50 million$9.48 millionViewListenView Earnings Details
11/12/2015Q315($0.11)($1.29)$8.10 million$8.30 millionViewListenView Earnings Details
8/13/2015Q215($0.31)($0.97)$0.20 million$0.61 millionViewListenView Earnings Details
5/14/2015Q1($0.37)($1.12)$0.25 million$0.08 millionViewN/AView Earnings Details
4/20/2015($0.37)($1.14)ViewN/AView Earnings Details
3/30/2015($0.59)($1.14)$0.28 million$0.37 millionViewN/AView Earnings Details
8/13/2014Q2$12.00$0.23 millionViewListenView Earnings Details
5/13/2014Q1($0.16)$0.10 millionViewListenView Earnings Details
3/17/2014Q4($0.09)$122.00 million$140.00 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.17)($0.17)$0.25 million$0.14 millionViewListenView Earnings Details
11/7/2012Q312($0.21)($0.17)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Strata Skin Sciences (NASDAQ:SSKN)
Current Year EPS Consensus Estimate: $-2.45 EPS
Next Year EPS Consensus Estimate: $-0.15 EPS

Dividends

Dividend History for Strata Skin Sciences (NASDAQ:SSKN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Strata Skin Sciences (NASDAQ:SSKN)
Insider Ownership Percentage: 14.53%
Institutional Ownership Percentage: 24.48%
Insider Trades by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
Institutional Ownership by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
Insider Trades by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/28/2016Frank J MccaneyCEOBuy20,000$0.51$10,200.00View SEC Filing  
3/11/2016Healthcare Master Fun BroadfinMajor ShareholderSell266,000$1.31$348,460.00View SEC Filing  
5/22/2014Anthony J DimunDirectorBuy87,500$0.38$33,250.00View SEC Filing  
2/5/2014David StoneDirectorBuy13,514$0.74$10,000.36View SEC Filing  
2/5/2014Robert CoradiniChairmanBuy67,567$0.74$49,999.58View SEC Filing  
2/5/2014Rosemary CraneCEOBuy67,570$0.74$50,001.80View SEC Filing  
6/28/2013Robert CoradiniCEOBuy15,000$0.99$14,850.00View SEC Filing  
6/27/2013Anne M EggerDirectorBuy11,000$0.90$9,900.00View SEC Filing  
6/27/2013Robert CoradiniCEOBuy15,000$0.87$13,050.00View SEC Filing  
6/26/2013Luann ViaDirectorBuy15,000$0.79$11,850.00View SEC Filing  
6/25/2013Richard I SteinhartCFOBuy3,000$0.81$2,430.00View SEC Filing  
6/24/2013Kathryn B SwintekDirectorBuy17,000$0.73$12,410.00View SEC Filing  
6/24/2013Robert CoradiniCEOBuy50,000$0.72$36,000.00View SEC Filing  
6/21/2013Kathryn B SwintekDirectorBuy3,000$0.79$2,370.00View SEC Filing  
6/20/2013Mindy C MeadsDirectorBuy5,070$0.79$4,005.30View SEC Filing  
6/19/2013David K StoneDirectorBuy10,000$0.82$8,200.00View SEC Filing  
5/3/2013Joseph V GulfoCEOBuy25,000$1.08$27,000.00View SEC Filing  
3/13/2013Joseph V GulfoCEOBuy20,000$1.15$23,000.00View SEC Filing  
11/12/2012Joseph V GulfoCEOBuy10,000$2.68$26,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Strata Skin Sciences (NASDAQ:SSKN)
Latest Headlines for Strata Skin Sciences (NASDAQ:SSKN)
Source:
DateHeadline
americanbankingnews.com logoStrata Skin Sciences, Inc. (SSKN) Short Interest Down 6.3% in April
www.americanbankingnews.com - May 19 at 8:26 PM
americanbankingnews.com logoStrata Skin Sciences, Inc. (SSKN) Given New $12.00 Price Target at Rodman & Renshaw
www.americanbankingnews.com - May 16 at 8:12 AM
finance.yahoo.com logoEdited Transcript of SSKN earnings conference call or presentation 11-May-17 8:30pm GMT
finance.yahoo.com - May 13 at 1:12 AM
reuters.com logoBRIEF-Strata Skin Sciences Q1 loss per share $1.03
www.reuters.com - May 12 at 2:44 AM
seekingalpha.com logoSTRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 2:44 AM
finance.yahoo.com logoInvestor Network: STRATA Skin Sciences, Inc. to Host Earnings Call
finance.yahoo.com - May 11 at 9:42 PM
finance.yahoo.com logoSTRATA Skin Sciences Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 11 at 9:42 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. Announces the Appointment of James L. Coyne to its Board of Directors
finance.yahoo.com - May 10 at 10:36 AM
seekingalpha.com logoStrata Skin up 5% on launch of new rejuvenation laser
seekingalpha.com - April 29 at 1:48 AM
streetinsider.com logoSTRATA Skin Sciences (SSKN) Announces Launch of Nordlys System; Sees FY17 Sales of $4M-4.5M from Device and Accessories
www.streetinsider.com - April 29 at 1:48 AM
reuters.com logoBRIEF-STRATA Skin Sciences says announces launch of the Nordlys system
www.reuters.com - April 27 at 8:17 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. to Report 1st Quarter 2017 Financial Results on Thursday, May 11
finance.yahoo.com - April 27 at 8:17 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. Announces Launch of the Nordlys System and Announces 2017 Revenue Expectations for Nordlys Hybrid System
finance.yahoo.com - April 27 at 8:17 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. Announces 1-for-5 Reverse Stock Split - Yahoo Finance
finance.yahoo.com - April 8 at 7:03 PM
reuters.com logoBRIEF-Strata Skin Sciences, Inc. Announces 1-for-5 reverse stock split
www.reuters.com - April 7 at 12:46 PM
reuters.com logoBRIEF-Strata Skin Sciences, Inc. Announces 1-for-5 reverse stock split
www.reuters.com - April 7 at 12:46 PM
streetinsider.com logoSTRATA Skin Sciences (SSKN) Says 1-for-5 Reverse Stock Split to Become Effective at 5 PM
www.streetinsider.com - April 7 at 12:46 PM
streetinsider.com logoSTRATA Skin Sciences (SSKN) Says 1-for-5 Reverse Stock Split to Become Effective at 5 PM
www.streetinsider.com - April 7 at 12:46 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. Announces 1-for-5 Reverse Stock Split
finance.yahoo.com - April 7 at 12:46 PM
prnewswire.com logoPsoriasis Drugs Among Leaders in Drug Side Effect Reporting - PR Newswire (press release)
www.prnewswire.com - March 31 at 3:17 PM
finance.yahoo.com logoPsoriasis Drugs Among Leaders in Drug Side Effect Reporting
finance.yahoo.com - March 31 at 3:17 PM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 30 at 8:17 PM
finance.yahoo.com logoSTRATA SKIN SCIENCES, INC. Financials
finance.yahoo.com - March 17 at 8:01 PM
News IconBRIEF-Strata Skin announces a strategic alliance with Ellipse USA
www.businessinsider.com - March 15 at 8:31 PM
us.rd.yahoo.com logo8:04 am STRATA Skin Sciences announces an agreement to license the exclusive US distribution rights for the Ellipse family of products from Ellipse USA
us.rd.yahoo.com - March 14 at 7:30 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. Announces a Strategic Alliance With Ellipse USA, LLC
finance.yahoo.com - March 14 at 9:17 AM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Other Events
biz.yahoo.com - March 14 at 9:17 AM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 13 at 7:39 PM
seekingalpha.com logoSTRATA Skin Sciences' (SSKN) CEO Frank McCaney on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 12:58 AM
reuters.com logoBRIEF-Strata Skin Sciences Q4 loss per share $0.09
www.reuters.com - March 9 at 7:58 PM
biz.yahoo.com logoQ4 2016 STRATA Skin Sciences Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 9 at 7:58 PM
us.rd.yahoo.com logoSTRATA Skin Sciences Reports Fourth Quarter and Full Year 2016 Financial Results
us.rd.yahoo.com - March 9 at 7:58 PM
finance.yahoo.com logoStrata Skin Sciences, Inc. (SSKN)
finance.yahoo.com - March 1 at 10:34 PM
finance.yahoo.com logoSTRATA Skin Sciences, Inc. to Report Fiscal Year End 2016 Financial Results on Thursday, March 9
finance.yahoo.com - February 23 at 8:14 PM
bizjournals.com logoAvadim CEO on 550 new North Carolina jobs, Triangle ties
www.bizjournals.com - December 8 at 9:08 PM
marketwatch.com logoPharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST From Valeant
www.marketwatch.com - December 8 at 8:15 AM
nasdaq.com logoMid-Morning Market Update: Markets Mostly Lower; Korn/Ferry Beats Q2 Expectations
www.nasdaq.com - December 8 at 8:15 AM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
biz.yahoo.com - December 6 at 8:28 AM
finance.yahoo.com logoEdited Transcript of SSKN earnings conference call or presentation 10-Nov-16 9:30pm GMT
finance.yahoo.com - November 14 at 11:53 AM
finance.yahoo.com logoSTRATA Skin Sciences Reports Third Quarter 2016 Financial Results
finance.yahoo.com - November 10 at 7:37 PM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
biz.yahoo.com - November 10 at 7:37 PM
biz.yahoo.com logoSTRATA Skin Sciences Inc Earnings Call (Q3 2016)
biz.yahoo.com - November 10 at 11:01 AM
biz.yahoo.com logoQ3 2016 STRATA Skin Sciences Inc Earnings Release - After Market Close
biz.yahoo.com - November 10 at 11:01 AM
biz.yahoo.com logoSTRATA Skin Sciences Inc Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - November 10 at 11:01 AM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
biz.yahoo.com - November 1 at 7:49 PM
finance.yahoo.com logo7:32 am STRATA Skin Sciences names Frank McCaney to replace Michael Stewart as its next President and CEO effective November 1
finance.yahoo.com - November 1 at 12:12 PM
biz.yahoo.com logoSTRATA SKIN SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Notice of Delisting or Fai
biz.yahoo.com - October 28 at 11:28 AM
finance.yahoo.com logoAesthetic Lasers Market Analysis by Application, and Segment Forecasts to 2024
finance.yahoo.com - September 22 at 11:38 AM
finance.yahoo.com logoEdited Transcript of SSKN earnings conference call or presentation 11-Aug-16 8:30pm GMT
finance.yahoo.com - August 19 at 7:27 PM
biz.yahoo.com logoSTRATA Skin Sciences Inc Earnings Call (Q2 2016)
biz.yahoo.com - August 11 at 10:54 AM

Social

Strata Skin Sciences (SSKN) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff